Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease
Retrieved on:
Wednesday, February 8, 2023
Biomarker, Evaluation, Small business, Stroke, World Health Organization, National Health Service, NHS health check, Splenic infarction, Patient, Digital technology, Pressure, Central London, Health, Mortality, HUMA, Health Check, Therapy, Risk, SBRI, Camden Health Partners, Health equity, NHS, Death, UCLPartners, Disease, Partnership, CVD, Cardiovascular disease, SBRI Healthcare, Medical device, Pharmaceutical industry, Nursing
People at risk of, or with, CVD are typically identified during an NHS Health Check.
Key Points:
- People at risk of, or with, CVD are typically identified during an NHS Health Check.
- Dr Alex Warner, Clinical Director at Camden Health Partners, said, "As Camden GPs we are excited about the potential for this programme.
- Kate Cheema, Director of Evaluation and Insights at UCLPartners, added: "UCLPartners is delighted to be working with HUMA as an evaluation partner.
- It is the single biggest condition4 where lives can be saved by the UK's NHS over the next decade.